Mast Cell Leukemia
Also known as: Mast Cell Leukemia (MCL) / Malignant Mast Cell Tumors / Malignant mast cell neoplasm / Malignant mast cell tumor / Mast cell sarcoma / Malignant mast cell neoplasm (morphologic abnormality) / Mast cell sarcoma (morphologic abnormality) / Malignant mast cell tumor (disorder) / Mast-Cell Sarcoma / Mast cell leukaemia / Mast cell leukemia not having achieved remission / Mast cell leukemia (morphologic abnormality) / Leukemia, Mast-Cell / Mast cell leukemia (disorder) / Mastocytic leukaemia / Mastocytic leukemia / Malignant mastocytosis (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB15233 | Avapritinib | A selective tyrosine kinase inhibitor being investigated for the treatment of multidrug resistant gastrointestinal tumors. |
DB06595 | Midostaurin | An antineoplastic agent used to treat high-risk acute myeloid leukemia (AML) with specific mutations, aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematologic neoplasm (SM-AHN), or mast cell leukemia (MCL). |